Impacts
- 14 results
Search results
-
Context aware text mining for the pharmaceutical sector
Nenadic, G. (Participant) & (Participant)
Impact: Economic, Technological, Health and wellbeing
-
Defining the phenotype of severe growth disorders, discovering new genes that control human growth and enhancing clinical practice
Clayton, P. (Participant), Black, G. (Participant), (Participant), Manson, F. (Participant), (Participant) & Patel, L. (Participant)
Impact: Health impacts
-
Exploiting an understanding of human visual perception to facilitate human-machine electrocardiogram interpretation of drug-induced long QT syndrome
Alahmadi, A. (Participant), Jay, C. (Participant), Vigo, M. (Participant), Davies, A. (Participant), (Participant), Goodwin, L. (Participant), (Participant), (Participant) & (Participant)
Impact: Technological, Health and wellbeing
-
Impact on the use of sodium valproate in women and girls of childbearing age
Bromley, R. (Participant) & (Participant)
Impact
-
Redressing health inequalities through evidence-based health and social care practice with Deaf sign language users
Young, A. (Participant), Rogers, K. (Participant), Ferguson-Coleman, E. (Participant), Oram, R. (Participant), (Participant), (Participant), Shields, G. (Participant), Keady, J. (Participant), Davies, L. (Participant) & Lovell, K. (Participant)
Impact: Health and wellbeing, Society and culture
-
Reducing future cancer risk and saving lives through testing women with endometrial (womb) cancer for Lynch syndrome
Crosbie, E. (Corresponding participant), Evans, D. (Participant), (Participant) & McMahon, R. (Participant)
Impact: Health and wellbeing, Economic, Policy
-
Seeking novel treatments for Complement-related diseases including age-related macular degeneration (AMD) and creation of spin out company Complement Therapeutics
Unwin, R. (Corresponding participant), Bishop, P. (Participant) & Clark, S. (Participant)
Impact: Health and wellbeing, Economic
-
The global impact of gene identification at the University of Manchester
(Participant), Tassabehji, M. (Participant), Dixon, M. (Participant), Black, G. (Participant), (Participant), Newman, W. (Participant), (Participant), (Participant), (Participant) & (Participant)
Impact: Health impacts, Economic impacts, Societal impacts
-
The miRBase database – an essential resource for tool development and pharmaceutical research
Griffiths-Jones, S. (Participant), (Participant) & (Participant)
Impact: Health impacts, Technological impacts, Economic impacts
-
The miRBase microRNA database – driving the development of commercial microRNA research tools, diagnostics and therapeutics
Griffiths-Jones, S. (Participant), (Participant) & (Participant)
Impact: Technological impacts, Economic, Health and wellbeing, Policy
-
The University of Manchester’s role in establishing nationally funded forefront services for neurofibromatoses
Evans, D. (Participant), (Participant) & (Participant)
Impact: Health impacts, Economic impacts, Societal impacts
-
Transforming the management of people with inherited eye disorders: a paradigm for the implementation of genomic medicine
Black, G. (Participant), Sergouniotis, P. (Participant), Ellingford, J. (Participant) & (Participant)
Impact: Health and wellbeing, Society and culture
-
World-first bedside genetic test to prevent babies going deaf
Newman, W. (Corresponding participant), Mcdermott, J. (Participant), Body, R. (Participant), Ulph, F. (Participant), Wilson, P. (Participant), Bruce, I. (Participant) & Beaman, G. (Participant)
Impact: Health and wellbeing, Economic, Technological, Policy
-
Worldwide reduction in the number of children exposed to harmful antiepileptic drugs in the womb
Bromley, R. (Participant) & (Participant)
Impact: Health and wellbeing, Policy